Atherogenic dyslipidemia and altered hepatic gene expression in SHRSP.Z-Leprfa/IzmDmcr rats

International Journal of Molecular Medicine

Volumn 23, Issue 3, 2009, Pages 313-320

  Ueno, Takahiro ^a   Fukuda, Noboru ^a,b   Nagase, Hiroki ^b   Tsunemi, Akiko ^a   Tahira, Kazunobu ^a   Matsumoto, Taro ^a   Hiraoka Yamamoto, Junko ^c   Ikeda, Katsumi ^c   Mitsumata, Masako ^a   Sato, Yuichi ^a   Soma, Masayoshi ^a   Matsumoto, Koichi ^a   Yamori, Yukio ^d  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^d International Center for Research on Primary Prevention of Cardiovascular Diseases   (Japan)

Author keywords

Fenofibrate; Metabolic syndrome; Microarray; Small dense low density lipid protein

Indexed keywords

ACYL COENZYME A DESATURASE; ADENOSINE TRIPHOSPHATE CITRATE LYASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; FATTY ACID SYNTHASE; FENOFIBRATE; LOW DENSITY LIPOPROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DYSLIPIDEMIA; GEL FILTRATION CHROMATOGRAPHY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC REGULATION; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIVER METABOLISM; METABOLIC SYNDROME X; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WESTERN BLOTTING; ZUCKER DIABETIC FATTY RAT; ANIMAL; GENETICS; LIVER; METABOLISM; PATHOLOGY; SPECIES DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT; ZUCKER RAT;

ANIMALS; APOLIPOPROTEINS B; CHOLESTEROL, LDL; DYSLIPIDEMIAS; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIVER; METABOLIC SYNDROME X; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, ZUCKER; SPECIES SPECIFICITY;

EID: 64249103599     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000133     Document Type: Article

References (37)

1. Hitsumoto T, Takahashi M, Iizuka T and Shirai K: Relationship between metabolic syndrome and early stage coronary atherosclerosis. J Atheroscler Thromb 14: 294-302, 2007.
2. Teramura M, Emoto M, Araki T, et al: Clinical impact of metabolic syndrome by modified NCEP-ATPIII criteria on carotid atherosclerosis in Japanese adults. J Atheroscler Thrombs 14: 172-178, 2007.
3. Yamada Y, Kato K, Oguri M, et al: Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome. Int J Mol Med 21: 801-808, 2008.
4. Liberopoulos EN, Mikhailidis DP and Elisaf MS: Diagnosis and management of the metabolic syndrome in obesity. Obes Rev 6: 283-296, 2005.
5. Gazi I, Tsimihodimos V, Filippatos T, Bairaktari E, Tselepis AD and Elisaf M: Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria. Metabolism 55: 885-891, 2006.
6. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421, 2002.
7. Gardner CD, Fortmann SP and Krauss RM: Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276: 875-881, 1996.
8. Nozue T, Michishita I, Ishibashi Y, et al: Small dense low-density lipoprotein cholesterol is a useful marker of metabolic syndrome in patients with coronary artery disease. J Atheroscler Thrombs 14: 202-207, 2007.
9. St-Pierre AC, Cantin B, Dagenais GR, et al: Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol 25: 553-559, 2005.
10. Hiraoka-Yamamoto J, Nara Y, Yasui N, Onobayashi Y, Tsuchikura S and Ikeda K: Establishment of a new animal model of metabolic syndrome: SHRSP fatty (fa/fa) rats. Clin Exp Pharmacol Physiol 31: 107-109, 2004.
11. fa/IzmDmcr Rats as a new model of metabolic syndrome. Hypertens Res 31: 1021-1031, 2008.
12. Elisaf M: Effects of fibrates on serum metabolic parameters. Curr Med Res Opin 18: 269-276, 2002.
13. Wysocki J, Belowski D, Kalina M, Kochanski L, Okopien B and Kalina Z: Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome. Int J Pharmacol Ther 42: 212-217, 2004.
14. Yoshino G, Hirano T and Kazumi T: Treatment of small dense LDL. J Atheroscler Thrombs 9: 266-275, 2002.
15. Tokuno A, Hirano T, Hayashi T, et al: The effects of statin and fibrate on lowering small dense LDL- cholesterol in hyperlipidemic patients with type 2 diabetes. J Atheroscler Thrombs 14: 128-132, 2007.
16. Kohjima M, Higuchi N, Kato M, et al: SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med 21: 507-511, 2008.
17. Lelliott CJ, Ljungberg A, Ahnmark A, et al: Hepatic PGC-1beta overexpression induces combined hyperlipidemia and modulates the response to PPARalpha activation. Arterioscler Thromb Vasc Biol 27: 2707-2713, 2007.
18. Nakamuta M, Kohjima M, Higuchi N, et al: The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease. Int J Mol Med 22: 663-667, 2008.
19. Adiels M, Olofsson SO, Taskinen MR and Boren J: Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 28: 1225-1236, 2008.
20. Adiels M, Taskinen MR, Packard C, et al: Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49: 755-765, 2006.
21. Tsujita M, Tomimoto S, Okumura-Noji K, Okazaki M and Yokoyama S: Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice. Biochim Biophys Acta 1485: 199-213, 2000.
22. Usui S, Hara Y, Hosaki S and Okazaki M: A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res 43: 805-814, 2002.
23. Wu CA, Tsujita M, Okumura-Noji K, et al: Cholesteryl ester transfer protein expressed in lecithin cholesterol acyltransferase-deficient mice. Arterioscler Thromb Vasc Biol 22: 1347-1353, 2002.
24. Lamarche B, St-Pierre AC, Ruel IL, Cantin B, Dagenais GR and Despres JP: A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men. Can J Cardiol 17: 859-865, 2001.
25. Stampfer MJ, Krauss RM, Ma J, et al: A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 276: 882-888, 1996.
26. Lamarche B, Lemieux I and Despres JP: The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab 25: 199-211, 1999.
27. Vakkilainen J, Steiner G, Ansquer JC, et al: Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS). Circulation 107: 1733-1737, 2003.
28. Qiu S, Bergeron N, Kotite L, Krauss RM, Bensadoun A and Havel RJ: Metabolism of lipoproteins containing apolipoprotein B in hepatic lipase-deficient mice. J Lipid Res 39: 1661-1668, 1998.
29. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E and Fruchart JC: Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98: 2088-2093, 1998.
30. Ntambi JM: Dietary regulation of stearoyl-CoA desaturase 1 gene expression in mouse liver. J Biol Chem 267: 10925-10930, 1992.
31. Elshourbagy NA, Near JC, Kmetz PJ, et al: Rat ATP citratelyase. Molecular cloning and sequence analysis of a full-length cDNA and mRNA abundance as a function of diet, organ, and age. J Biol Chem 265: 1430-1435, 1990.
32. Flowers MT, Miyazaki M, Liu X and Ntambi JM: Probing the role of stearoyl-CoA desaturase-1 in hepatic insulin resistance. J Clin Invest 116: 1478-1481, 2006.
33. Enoch HG, Catala A and Strittmatter P: Mechanism of rat liver microsomal stearyl-CoA desaturase. Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipid. J Biol Chem 251: 5095-5103, 1976.
34. Dobrzyn A and Ntambi JM: The role of stearoyl-CoA desaturase in body weight regulation. Trends Cardiovasc Med 14: 77-81, 2004.
35. Ntambi JM, Miyazaki M, Stoehr JP, et al: Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 99: 11482-11486, 2002.
36. Ayyobi AF and Brunzell JD: Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia. Am J Cardiol 92: 27J-33J, 2003.
37. Montanaro MA, Rimoldi OJ, Igal RA, et al: Hepatic delta9, delta6, and delta5 desaturations in non-insulin-dependent diabetes mellitus eSS rats. Lipids 38: 827-832, 2003.